# AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding

> **NCT04804345** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 693 (actual)

## Conditions studied

- Cardiac Surgery
- Cardiopulmonary Bypass
- High Risk Bleeding

## Interventions

- **OTHER:** standard of care

## Key facts

- **NCT ID:** NCT04804345
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-31
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 693 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04804345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04804345, "AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04804345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*